Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs (Q39546203)

12 September 2017

Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs (English)

1 reference

12 September 2017

1 reference

1 reference

I K Guttilla

1

1 reference

12 September 2017

K N Phoenix

2

1 reference

12 September 2017

X Hong

3

1 reference

12 September 2017

J S Tirnauer

4

1 reference

12 September 2017

K P Claffey

5

1 reference

12 September 2017

B A White

6

1 reference

12 September 2017

language of work or name

English

0 references

publication date

7 May 2011

1 reference

Breast Cancer Research and Treatment

12 September 2017

1 reference

12 September 2017

132

1 reference

12 September 2017

1

1 reference

12 September 2017

75-85

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-011-1534-y

12 September 2017

0 references

cites work

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

How different are luminal A and basal breast cancers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

The basics of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Biomarkers for epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Targeted deletion of Prkar1a reveals a role for protein kinase A in mesenchymal-to-epithelial transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Epithelial-mesenchymal transitions in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

ERalpha signaling through slug regulates E-cadherin and EMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

MicroRNAs and metastasis: little RNAs go a long way

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Palate morphogenesis: current understanding and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Snail family regulation and epithelial mesenchymal transitions in breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

MicroRNAs and their target gene networks in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Protocol: a highly sensitive RT-PCR method for detection and quantification of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

The ups and downs of miR-205: identifying the roles of miR-205 in mammary gland development and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and a luminal phenotype in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Breast cancer stem cells: tools and models to rely on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1534-Y

10.1007/S10549-011-1534-Y

21 January 2018

Identifiers

DOI

1 reference

release_sevxbbh63vfzzhlbbhtops5sgu

12 September 2017

0 references

1 reference